Response by Elliott et al to Letter Regarding Article, “Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy”
Author:
Affiliation:
1. University College London, United Kingdom (P.E.).
2. Pfizer Inc, Groton, CT (B.G.).
3. Pfizer Inc, New York, NY (M.B.S.).
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference5 articles.
1. Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
2. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
3. Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany
4. Clinical characteristics and natural history of wild‐type transthyretin amyloid cardiomyopathy in Japan
5. DOES TAFAMIDIS BENEFIT OCTOGENARIANS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY? ANALYSIS OF THE CLEVELAND CLINIC AMYLOID REGISTRY
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis;ESC Heart Failure;2024-08-24
2. Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS);Journal of Cardiac Failure;2024-06
3. Transthyretin Cardiac Amyloidosis: Increasing Evidence of the Benefits of A TTRansformation in Diagnostic and Treatment Strategies.;Journal of Cardiac Failure;2024-05
4. Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study;JACC: Heart Failure;2024-01
5. Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy;ESC Heart Failure;2023-04-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3